# Treatment of AD With IgE Specific Immunoadsorption (IGEIAAD)

> **NCT02365246** · PHASE2 · RECRUITING · sponsor: **Universitaire Ziekenhuizen KU Leuven** · enrollment: 15 (estimated)

## Conditions studied

- Atopic Dermatitis

## Interventions

- **DEVICE:** immunoadsorptions with an IgE-specific adsorption column

## Key facts

- **NCT ID:** NCT02365246
- **Lead sponsor:** Universitaire Ziekenhuizen KU Leuven
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2014-08
- **Primary completion:** 2025-12
- **Final completion:** 2025-12
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2024-07-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02365246

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02365246, "Treatment of AD With IgE Specific Immunoadsorption (IGEIAAD)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02365246. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*